2023 Speakers

2023 Speakers:


“I look forward to connecting with the community of mRNA drug development experts to discuss our challenges and opportunities in this nascent sector of the biotech market”

- Senior Director – Quality from Cartesian Therapeutics

Aleš Štrancar

Executive Managing Director

Sartorius BIA Separations

Andreas Kuhn

Senior Vice President - RNA Biochemistry & Manufacturing

BioNTech SE

Anna Saernefaelt

CMC Lead

Coalition for Epidemic Preparedness Innovations

Camilla Foged

Professor

University of Copenhagen

Eivor Örnskov

Associate Principal Scientist

AstraZeneca

Elaine Peters

Director, Analytical Capabilities Cell & Gene Therapy

Genentech

Frank Eggert

Associate Director Cap Technology

BioNTech AG

Harris Makatsoris

Professor Of Sustainable Manufacturing Systems

King's College London

Ike James

Head of Technology Transfer

Medicines Patent Pool

José Castillo

Chief Executive Officer

Quantoom Biosciences

Julen Oyarzabal

CSO and Founder

Syngoi

Lena Wicke

Senior Director RNA Process Development

BioNTech SE

Marie Bosnes

Researcher

Thermo Fisher Scientific

Mark Dickman

Professor

University of Sheffield

Mark McElligott

Principal Process Engineer

bioX

Michael Thommen

Senior Scientist Early Process Development

CureVac

Patrick Thiaville

Chief Technology Officer, Nucleic Acids

Exothera

Roland Pach

Global Expert - Cell Gene Therapy, Analytics Chemistry, Manufacturing & Controls

Roche

Steve Pascolo

Senior Scientist

University Hospital Zurich

Taylor Scott

Sr Scientist

GeneLeap BioTech

Tilmann Roos

Senior Director Technical Development RNAPrinter

CureVac